JCEM Author Guidelines
Aims and Scope
The Journal of Clinical Endocrinology & Metabolism is the world’s leading peer-reviewed journal for the dissemination of original research as it relates to the clinical practice of endocrinology, diabetes, and metabolism. Spanning the full spectrum of translational research from discovery science to experimental medicine and from critical evaluation of new treatments to patient-population-related outcomes, each issue provides up-to-date coverage of novel developments that enhance our understanding of the pathophysiology, diagnosis, and treatment of endocrine and metabolic disorders. JCEM also publishes articles that reveal insight into the metabolic-endocrine basis for, or treatment of, other human conditions including cardiovascular disease, cancer, and aging. Over and above new findings submitted from researchers across the globe, regular features of special interest include personal perspectives and commentaries on new developments, results of prismatic clinical trials, mini-reviews, and clinical practice guidelines.
More about the journal
Editor-in-Chief, Associate Editors, and Editorial Board
Contents
Article Types
•Original Articles
•Clinical Research Article
•Approach to the Patient
•Review Articles
•Mini-review
•Meta-analysis
•Opinion and Comment
•Editorial
•Commentary
•Perspective
•Letter to the Editor
•Letter to the Editor Response
•Reports and Recommendations
•Endocrine Society Communications
•Clinical Practice Guideline
•Clinical Practice Guideline Meta-analysis
•Clinical Practice Guideline Systematic Review
•Clinical Practice Guideline Communication
•Clinical Practice Guideline Updates
•Clinical Practice Guideline Alerts
•Policy Perspective
•Research Guide
•Scientific Statement
•Consensus Statement
•Position Statement
Publication Fees and Open Access
•Publication Fees
•Use of Previously Published Figures and Tables in Mini-reviews
•Post-Publication Access Policies and Funder Requirements
Manuscript Preparation Guidelines and Checklist
•Guidelines on General Preparation of Initial Submissions
•Guidelines on General Preparation of Revised Submissions
•Permission to Reproduce or Adapt Figures/Tables
•Units of Measure and Standard Abbreviations
•Steroid Nomenclature Standards
•Checklist and Guidelines
•Title Page
•Abstract
•Introduction
•Materials and Methods
•Results
•Discussion
•Acknowledgments
•Data Availability
•References
•Legends for Figures and Tables
•Tables
•Figure Guidelines
•Supplemental Data
Ethical Issues and Conduct
•Authorship Criteria and Obligations
•Preprints, Prior Publication, and Author Self-Archiving
•Experimental Subjects
•Experimental Animals
•Obligations of Reviewers
•Scientific Misconduct
Editorial Guidelines and Policies
•Peer Review Process
•Reporting the Sex of Research Subjects
•Reporting the Sex of Research Animals
•Study Data Guidelines
•Validation of Data and Statistical Analysis
•Reporting of Steroid Hormone Measurements
•Cell Line Authentication
•Genome-wide and Candidate Gene Studies
•Transcriptomic Studies
Data Repositories and Data Registration
•Clinical Trials Registration
•Resource Deposits
•Antibody and ELISA Requirements
•Data Availability
•New Amino Acid or Nucleotide Sequences and New/Novel Compounds
•Genomic, Proteomic, and Bioinformatic Papers
•Extended Data Sets and Supplemental Materials
Author Services and Information
•Language-Editing, Original Figure Preparation, and Related Services
•Embargo Policy
Operations Policies
•Editorial Office Archiving Procedures
•Affirmation of Originality and Authorship, Conflict of Interest Disclosure and Exclusive License to Publish
Article Types
The following types of articles, including preprints from recognized repositories, will be considered for publication:
Original Articles
Clinical Research Articles are original, investigative, clinical studies based on previously unpublished data. There are no upper or lower word/figure/table limits. All figures and tables must be original.
Approach to the Patient articles use illustrative clinical scenarios as the basis for discussion of the background to the diagnoses and/or the considerations in devising a therapeutic strategy in similar cases. They should reference any pertinent clinical practice guidelines, treatment recommendations, and other literature, particularly any relevant newly published literature. All figures and tables must be original. Approach to the Patient articles range from 2,000 to 5,000 words in length and are submitted by invitation from the Editor-in-Chief or a Deputy Editor.
Review Articles
Mini-reviews are short reviews, ranging from 2,000 words to a maximum of 5,000 words, that are intended to reach a broad spectrum of endocrinologists. Mini-reviews should integrate the latest discoveries with the current literature, providing critical analytical interpretation of the significance of any new information described. Authors should include a brief section describing the search strategies used to obtain information for the review. If the authors choose to use previously published figures or tables, they must follow the guidelines under the Publication Fees section.
Meta-analyses should focus on specific efficacies of diagnostic procedures or treatments. The submitted manuscript must be derived from an in-depth statistical analysis of information discovered by an exhaustive search of already published and relevant peer-reviewed manuscripts. Submissions of this type must include an outline and a narrative statement. There are no limits on word count, number of figures, or number of references. All figures and tables must be original.
Opinion and Comment
Editorials are opinion articles by the journal's Editor-in-Chief or an Associate Editor and will typically address a timely policy matter of very high importance to endocrinologists. Editorials carry no figures or tables and have no more than eight references.
Commentaries are opinion articles invited by the Editor-in-Chief that will examine concepts and findings recently introduced into the scientific record that have exceptional interest. They are typically up to 1,000 words in length, should have no more than eight references, and have no figures or tables. Commentaries should not cite unpublished work or data.
Perspectives present a new viewpoint on policies and generally accepted principles and practices in endocrinology that warrant closer examination based on very recent newly published data. They should cite relevant literature and are typically no longer than 2,400 words, have no more than eight references, and have no figures or tables. Perspectives should not cite unpublished work or data. Perspectives are submitted by invitation from the Editor-in-Chief.
Letters to the Editor should discuss only articles published in final format in this journal, and be submitted within six months of the article’s final publication. (Concerns about Advance Articles should be brought to the attention of the Executive Editor.) Letters must be no more than 500 words in length, have no more than eight references, and must not cite unpublished work or data. Letters will be published at the discretion of the Editor-in-Chief. Authors of accepted letters see page proofs before publication. Only changes to correct inadvertent/introduced grammar and/or spelling inaccuracies are permitted. Regular publication charges apply. No figures or tables are allowed. The title of the letter should follow the format of “Letter to the Editor: [Title of Original Article being Discussed]”. Should your title not follow this format, it will be standardized by the publisher.
Letters to the Editor Responses reply to a Letter to Editor at no greater length than the original letter. Authors whose work is discussed in a Letter to the Editor will typically be invited to provide a response. If accepted, authors will see page proofs before publication. Only changes to correct inadvertent/introduced grammar and/or spelling inaccuracies are permitted. No figures or tables are allowed. The title of the letter should follow the format of “Response to Letter to the Editor: [Title of Original Article being Discussed]”. Should your title not follow this format, it will be standardized by the publisher.
Reports and Recommendations present a summary of the proceedings and conclusions of work groups, task forces, and other collaboratives. They will be subject to peer review and must be modifiable in response to criticisms. They are typically no more than 3,600 words in length. All figures and tables must be original. If interested in submitting, contact the Editorial Office at publications@endocrine.org.
Endocrine Society Communications
The following article types are official Endocrine Society communications:
Clinical Practice Guidelines are developed by an Endocrine Society appointed task force, are evidence based, and provide graded clinical practice recommendations. These are developed with input from Society committees and members.
Clinical Practice Guideline Meta-analyses are commissioned by the Endocrine Society to provide statistical analyses to support its Clinical Practice Guidelines.
Clinical Practice Guideline Systematic Reviews are commissioned by the Endocrine Society for its Clinical Practice Guidelines. These reviews address a defined clinical question by collecting and summarizing empirical evidence that fits pre-specified eligibility criteria.
Clinical Practice Guideline Communications are derivatives of the Endocrine Society's Clinical Practice Guidelines that supplement or comment on developments in the disease area since the time of publication of a Guideline.
Clinical Practice Guideline Updates are developed to address interim changes in prevention, diagnosis, or management in an existing Endocrine Society Clinical Practice Guideline since the time of publication of a Guideline.
Clinical Practice Guideline Alerts are focused communications in response to new developments that significantly alter recommendations in an existing Endocrine Society Clinical Practice Guideline (e.g., important new drug approval(s), important drug withdrawal(s), important new risks or harms). These address changes that impact the validity of a guideline and affect patient safety.
Policy Perspectives are based on established Society policy positions and developed by the Advocacy & Public Outreach Core Committee with input from the membership.
Research Guides are developed by an expert writing group under the direction of the Research Affairs Core Committee.
Scientific Statements are developed by an expert writing group under the direction of an Endocrine Society appointed Chair with input from Society committees and the membership.
Consensus Statements are developed by an expert writing group under the direction of an Endocrine Society appointed Chair with input from Society committees.
Position Statements are documents that reflect the Society’s position or response to an issue. They are developed in consultation with member experts and under direction of a Committee. They are vetted by a Committee or Task Force; undergo a public comment period, if appropriate; and are approved by the Society’s Board.
Use of Peer Review: All submissions are subject to external peer review as directed by the journal editors, other than (1) Endocrine Society Communications, which are reviewed by the Endocrine Society and selected outside experts, and (2) meeting abstracts, which, when published as a supplement to Journal of the Endocrine Society, have been reviewed by the Endocrine Society’s Annual Meeting Steering Committee.
Questions? Please direct any questions to publications@endocrine.org.
Publication Fees and Open Access
Publication Fees
For more information on the benefits of membership in the Endocrine Society, please visit the Member Benefits page of the Endocrine Society’s website.
Page Charges
Endocrine Society members: $99 per PDF page
Non-members: $119 per PDF page
Color Charges
Endocrine Society members: $235 per color figure
Non-members: $735 per color figure
Letter to the Editor Charge
Endocrine Society members: $99 per PDF page
Non-members: $99 per PDF page
Optional Upgrade to Open Access
The Journal of Clinical Endocrinology & Metabolism offers the option of publishing under either a standard licence or an open access licence. Please note that some funders require open access publication as a condition of funding. If you are unsure whether you are required to publish open access, please do clarify any such requirements with your funder or institution.
Should you wish to publish your article open access, you should select your choice of open access licence in our online system after your article has been accepted for publication. You will need to pay an open access charge to publish under an open access licence.
Details of the open access licences and open access charges.
Questions about licences and charges can be sent to jnls.author.support@oup.com.
OUP has a growing number of Read and Publish agreements with institutions and consortia which provide funding for open access publishing. This means authors from participating institutions can publish open access, and the institution may pay the charge. Find out if your institution is participating.
Use of Previously Published Figures and Tables in Mini-reviews
Authors are responsible for obtaining the appropriate permissions to reproduce or adapt previously published figures or tables. Because publishers frequently hold copyright, this often applies to an author’s own materials. We strongly encourage authors to submit original figures and tables when possible instead of using previously published materials. For assistance on preparing original figures and tables, authors should consider contacting American Journal Experts.
If an author chooses to reproduce or adapt a previously published figure or table in a mini-review, the following procedure applies:
The author agrees to obtain the permissions prior to submission and is responsible for all expenses related to securing authorization to use the previously published figure or table.
The author will provide the editorial office with a copy of the permissions or copyright form with their submission files. This includes copies of articles in the public domain or that carry a CC-BY license.
The Copyright Clearance Center is often the easiest way for authors to clear permissions to reproduce or adapt any figures or tables that have been previously published. If you have any questions regarding the specifications required for permissions, please contact publications@endocrine.org
The permissions must include the following:
non-exclusive rights to reproduce the material in the specified article and journal;
print and electronic rights, preferably for use in any form or medium;
the right to use the material for the life of the work; and
world-wide English-language rights.
If the author does not finalize the required permissions, the author must either replace the reproduced or adapted content with original material or delete the content and any corresponding references to it.
The author must include a credit line for all material being reproduced or adapted in a paper. The credit line must include the source information of the original table or figure. If the copyright holder does not provide an author with a specific credit line, the author/date text citation and the words “with permission” should be used.
If material has been adapted, the words “adapted from” should be included along with the author/date citation (e.g., “Adapted from Jones 2008”).
If material has been reproduced, the words “reproduced from” should be included along with the author/date citation (e.g., “Reproduced from Jones 2008”).
The author understands that all issues related to the use of previously published figures and tables as outlined above must be resolved before the revised manuscript can be considered.
Copyright usually resides with the creator of the work—the author, artist, or other originator. However, when a work is published, the creator usually licenses the copyright to the publisher and loses control over it while the licence is in force. This means that the agreement of the author to re-use material does not constitute copyright permission. To seek permission to reproduce a published work, you must approach the rights holder, which is usually the publisher. Also note that if the work was made in the course of employment, copyright is owned by the employer unless a contract specifies otherwise.
Post-Publication Access Policies and Funder Requirements
Articles funded by the National Institutes of Health (NIH), Wellcome Trust, Howard Hughes Medical Institute (HHMI), and Canadian Institutes of Health Research (CIHR) will be submitted to PubMed Central after final issue publication and will be made freely available in 12 months.
There are additional US Government Agencies and private funders that have partnerships with the National Library of Medicine to leverage the PubMed Central infrastructure. A list of these organizations can be found. For specific information on how to comply with the policies of these funders, please see their websites. Information on depositing a paper in PubMed Central in compliance with a public access policy.
Please note that some funders (such as the Wellcome Trust and Research Councils UK) may require publication under an Open Access license and subsequent payment of a fee. Open access costs and publication charges are authorized grant expenses for which authors can seek reimbursement from the Wellcome Trust, Research Councils UK, or funders operating under their policies. These articles will contain the following language: "This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY; Creative commons website), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited."
If your manuscript is accepted for publication, you will be asked at the proof stage to confirm the funding source of your paper and to agree to pay any applicable post-publication access fees.
Reimbursement: The Endocrine Society will consider requests for reimbursement of APCs from funder and institutional customers in the event that we do not materially comply with their Open Access requirements. Contact publications@endocrine.org.
Manuscript Preparation Guidelines and Checklist
Below is a checklist of the basic format requirements. For more information, see Editorial Policies. If you have any questions, contact the editorial staff at publications@endocrine.org.
Guidelines on General Preparation of Initial Submissions
Read the Editorial Policies. NOTE: Endocrine Society journals allow submissions from preprints: see Preprint Repositories and Prior Publication.
Format Neutral Submission: New manuscripts may be submitted format neutral, as a single Word, RTF, or PDF file with continuous line numbering. Technical formatting such as reference layout and order of components is not scrutinized for compliance at this initial stage. If the required information is present (complete title page, all author information, abstract, full text, line numbering, figures and tables, references, etc.) the manuscript will be assessed solely on its scientific merit. Note that metadata extraction will work only for manuscripts uploaded as Word files.
Submit paper in English through the Editorial Manager system.
Use a double-spaced, single-column format with 1-inch margins.
Use continuous line numbering throughout the manuscript. Manuscripts submitted without line numbers will be returned.
Paginate the entire document.
Place all tables and figures after the references and clearly label each.
Gather needed information prior to starting the submission process in Editorial Manager:
Full names, institutions, and email addresses for each author.
Submitting authors are required to provide an ORCiD when uploading a manuscript.
Appropriate funding information for each author.
Disclosure information for each author.
Names and email addresses for three recommended reviewers.
Original manuscript number if manuscript being submitted was previously rejected by the journal to which it is being resubmitted.
No cover letter is needed. A text block is provided during the submission process for special requests.
Appropriate figure file specifications as detailed in the Figure Guidelines have been followed.
Guidelines on General Preparation of Revised Submissions
At revision, two versions of your manuscript will be required: (1) A marked-up copy to be used for editor and reviewer purposes that indicates all changes made to the text, legends, and tables with either highlighting, colored text, or tracked changes and (2) A clean, un-marked copy that has all color and mark-up removed from text, legends, and tables that will be used by production, should your manuscript be accepted. Both versions of your manuscript should be prepared in and submitted as MS Word files.
Please note that aside from one copy showing color or markup, the two copies of your manuscript should both include all revisions and be identical. The clean copy should contain all revisions reflected in the marked-up version, but have tracked changes accepted and highlighting/colored text reverted to black and white.
Use continuous line numbering throughout both the marked manuscript and the clean manuscript document. Manuscripts submitted without line numbers will be returned.
Permission to Reproduce or Adapt Figures/Tables
Adapted and reproduced figures and tables are allowed only in mini-reviews. Note that the permissions staff will assist the author with identifying the appropriate type of permission to obtain. When determining the status of a figure / table, please use these definitions:
ORIGINAL: If you created a figure or table specifically for the work being submitted, this is an original and no permissions are required.
REPRODUCED: If a figure or table appears in a new publication exactly as it appeared in the original publication, then it is reproduced. Permission must be given by the publisher and attribution to the original source must be provided.
ADAPTED: If a figure or table is adapted, it is modified from its original appearance but still closely resembles the original. Permission must be given by the publisher and attribution to the original source must be provided.
If a figure or table uses elements from another source, or multiple sources, authors are responsible for determining if the figure is “Adapted” or “Transformative”.
……
更多详情：
https://academic.oup.com/jcem/pages/Author_Guidelines
